Oxypertine

Oxypertine

SCHEMBL5069690

COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC.N

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.98
▸ HTR1A P08908 2/20 0.98
▸ NR1I2 O75469 1/20 0.98
▸ ADRB1 P08588 1/20 0.98
▸ ADRA2A P08913 1/20 0.98
▸ ADORA3 P0DMS8 1/20 0.98
▸ ADRA2B P18089 1/20 0.98
▸ ADRA2C P18825 1/20 0.98
▸ SLC6A2 P23975 1/20 0.98
▸ HTR2A P28223 1/20 0.98
▸ HTR2C P28335 1/20 0.98
▸ PTGS2 P35354 1/20 0.98
▸ HRH1 P35367 1/20 0.98
▸ HTR2B P41595 1/20 0.98
▸ CHRNA4 P43681 1/20 0.98
▸ SLC6A3 Q01959 1/20 0.98
▸ PDE4D Q08499 1/20 0.98
▸ KCNH2 Q12809 1/20 0.98
▸ HTR7 P34969 1/20 0.48
▸ MAPT P10636 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxypertine SCHEMBL1515 0.99 DRD2 (1.00) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL31153315 0.99 DRD2 (1.00) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL2463001 0.99 DRD2 (1.00) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL3478579 0.98 DRD2 (0.98) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL3440995 0.98 DRD2 (0.98) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL20270862 0.98 DRD2 (0.98) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL21268763 0.96 HTR1A (0.94) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL2837214 0.96 DRD2 (0.94) DRD2HTR1ANR1I2ADRB1ADRA2A
Oxypertine SCHEMBL7527152 0.93 HTR1A (0.88) DRD2HTR1ANR1I2ADRB1ADRA2A
SCHEMBL2615395 0.91 DRD2 (0.84) DRD2HTR1ANR1I2ADRB1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948798-A1 ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES Glenmark Pharmaceuticals S.A. (CH) 2008-07-30 — — EP claimed
WO-2007056858-A1 ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES GLENMARK PHARMACEUTICALS S.A. (CH) 2007-05-24 — — WO claimed
Send feedback